retatrutide triple agonist clinical trials Today, we shared new data from two Phase 3 of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v Triple hormone receptor agonist retatrutide

Olfati KarajiRDaghigh KiaHAshrafiI

Practical protocols for researchers with thyroid nodules Moving from evidence review to practical application, here is exactly what researchers with thyroid nodules should consider before, during, and while maintaining tirzepatide therapy

Also approved in 2024 for obstructive sleep apnea

Enhanced Oxidative Stress Management Oxidative stress occurs when there is an imbalance between free radicals and the antioxidants meant to neutralize them

Palmitoyl tripeptide-5 and derivatives Several derivatives have been developed in the 2000s-2010s: Palmitoyl tripeptide-1 (Pal-GHK): combination of native GHK with a palmitic chain for improved topical penetration Palmitoyl tripeptide-5 (Pal-KVK): TGF- growth factor mimetic, documented as collagen inducer Palmitoyl tetrapeptide-7 (Pal-GQPR): studied for cutaneous anti-inflammatory effect These variants all exploit the same principle: short signal peptide + lipid chain for improved membrane penetration while preserving biological activity